Interventional Oncology Devices | Market Insights | Japan | 2021
Despite short-term contraction caused by the ongoing COVID-19 pandemic, as well as delays in the availability of new technologies due to strict regulations and the use of alternative treatments, the Japanese market for interventional oncology devices will grow moderately over the forecast period due to an expanding patient pool, the increasing adoption of minimally invasive techniques, and the introduction and adoption of premium-priced devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.
